A carregar...
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function and macular thickness in healthy volunteers
AIM: Fingolimod, a sphingosine 1-phosphate receptor modulator, is the first oral disease modifying therapy approved for the treatment of relapsing multiple sclerosis. The aim of this double-blind, placebo-controlled study was to evaluate the effect of fingolimod on cerebral blood flow, platelet func...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BlackWell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4256624/ https://ncbi.nlm.nih.gov/pubmed/24976291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12454 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|